Your shopping cart is currently empty

EGFR/HER2-IN-14 (Compd 46) serves as an inhibitor for drug-resistant mutant EGFR/HER2s. This compound is utilized in cancer research.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $2,270 | 3-6 months | 3-6 months | |
| 50 mg | $2,980 | 3-6 months | 3-6 months | |
| 100 mg | $4,000 | 3-6 months | 3-6 months |
| Description | EGFR/HER2-IN-14 (Compd 46) serves as an inhibitor for drug-resistant mutant EGFR/HER2s. This compound is utilized in cancer research. |
| In vitro | EGFR/HER2-IN-14 exhibits an IC50 of less than 100 nM in Ba/F3 cells transfected with EGFR exon 20 insASV/insSVD and HER2 exon 20 insGSP/insYVMA mutations [1]. |
| Molecular Weight | 575.62 |
| Formula | C32H29N7O4 |
| Cas No. | 3034701-54-4 |
| Smiles | O=C(C=C)NC1=CC=CC(=C1)N2C(=O)C(=CC=3C=NC(=NC32)NC=4C=CC(=NC4OC)N5CCOCC5)C6=CC=CC=C6 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.